VACCINE AGAINST CATTLE BRUCELLOSIS

FIELD: microbiology. SUBSTANCE: vaccine has bacterial mass of the strain B. abortus VGNKI N KV 17/100 inactivated with aluminium hydroxide as an antigen. Vaccine has also noncomplete Freund's adjuvant and physiological solution. The use of the a vaccine in veterinary ensures to increase effecti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KALMYKOV V.V, SHUMILOV K.V
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: microbiology. SUBSTANCE: vaccine has bacterial mass of the strain B. abortus VGNKI N KV 17/100 inactivated with aluminium hydroxide as an antigen. Vaccine has also noncomplete Freund's adjuvant and physiological solution. The use of the a vaccine in veterinary ensures to increase effectiveness of antibrucellosis actions by 1.5-2-fold due to increase of immunogenicity and decrease of agglutinogenicity of vaccine. EFFECT: vaccine indicated above, enhanced effectiveness of vaccine. 2 tbln